Axsome Therapeutics, Inc. (AXSM)

CIK 1579428 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Axsome Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 3, 202640001193125-26-382277
Sep 3, 20261440001958244-26-000571
Aug 10, 202610-Q0001193125-26-342360
Aug 10, 20268-K0001193125-26-341206
Aug 7, 202640001193125-26-340688
Aug 6, 20261440001958244-26-000491
Aug 5, 20261440001958244-26-000488
Jul 27, 2026SCHEDULE 13G/A0002012383-26-002197
Jul 15, 20268-K0001193125-26-304039
Jul 1, 20261440001958244-26-000417
Jul 1, 202640001193125-26-292985
Jun 11, 202640001193125-26-268202
Jun 11, 20261440001921094-26-000636
Jun 10, 202640001193125-26-266435
Jun 10, 202640001193125-26-266437
Jun 10, 20261440001921094-26-000633
Jun 10, 20261440001921094-26-000632
Jun 10, 202640001193125-26-266433
Jun 10, 20261440001921094-26-000631
Jun 10, 202640001193125-26-266436
Jun 9, 20261440001921094-26-000618
Jun 9, 20261440001921094-26-000619
Jun 9, 20268-K0001193125-26-264047
Jun 9, 202640001193125-26-264034
Jun 9, 202640001193125-26-264038